文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

大分割放疗使妇科恶性肿瘤继发阴道出血患者止血更快

Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy.
PubMed 文献 · Radiat Oncol · 2022-02-14

回顾性分析2012至2020年接受外照射放疗的43例妇科恶性肿瘤持续阴道出血患者,其中26例接受常规分割放疗(CFRT),17例接受大分割放疗(HFRT)。HFRT组止血中位时间5天,CFRT组16天,log-rank p<0.001;多因素分析中HFRT是唯一与止血时间显著相关的因素(HR 3.26,p=0.008)。

要点

  • HFRT组止血中位时间5天,CFRT组16天(log-rank p<0.001)。
  • 多因素分析中HFRT是唯一与止血时间显著相关的因素(HR 3.26,p=0.008)。
  • 按单次剂量分层显示随单次剂量增加止血更快的剂量-反应效应。

核心结论

  • 妇科肿瘤所致持续阴道出血患者接受HFRT较CFRT止血更快。
  • 对于严重阴道出血患者,启动HFRT以快速控制恶性肿瘤相关出血可能是有依据的。

研究设计与样本

  • 回顾性分析2012至2020年在本部门接受外照射放疗的妇科恶性肿瘤持续阴道出血患者,共43例。
  • HFRT定义为>2.0 Gy/fx,CFRT定义为1.8-2.0 Gy/fx;HFRT组17例,CFRT组26例。
  • 主要终点为从放疗开始至出血停止的天数;组间特征比较采用Fisher精确检验,止血时间采用Kaplan-Meier法和log-rank检验,采用单因素和多因素Cox比例风险模型识别与止血相关的因素。

主要发现

  • HFRT组止血中位时间5天 vs CFRT组16天(log-rank p<0.001)。
  • 按单次剂量分层显示剂量-反应效应,单次剂量增加止血更快。
  • 单因素分析中HFRT、年龄、复发疾病、既往盆腔放疗和既往全身治疗与止血时间相关。
  • 最终多因素模型中HFRT是唯一与止血时间显著相关的因素(HR 3.26,p=0.008)。
  • 基线比较显示HFRT组年龄更大(p=0.001)、更可能为绝经后(p=0.002)、更少接受同步化疗(p=0.004)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaginal bleeding (VB) is common in women with gynecologic (GYN) malignancies. Radiation therapy (RT) is used for the definitive treatment of GYN cancers and palliation of bleeding. The historical dogma is that high dose-per-fraction radiation leads to more rapid bleeding cessation, yet there is scant data supporting this claim. We sought to examine the effect of RT fraction size on VB via retrospective analysis of patients receiving hypofractionated radiation (HFRT) compared to conventionally fractionated radiation (CFRT) for control of bleeding secondary to GYN malignancies. METHODS: We identified patients receiving external beam RT for continuous VB from GYN malignancy treated in our department from 2012 to 2020. RT was classified as HFRT (> 2.0 Gy/fx) or CFRT (1.8-2.0 Gy/fx). Demographic information, disease characteristics, and treatment details were collected. The primary endpoint was days from RT initiation until bleeding resolution. Characteristics between groups were compared via Fisher's exact test. Time to bleeding cessation was assessed via Kaplan-Meier and log-rank test. Univariable and multivariable Cox-proportional hazards were used to identify factors associated with bleeding cessation. RESULTS: We identified 43 patients meeting inclusion criteria with 26 and 17 patients receiving CFRT and HFRT, respectively. Comparison of baseline characteristics revealed patients receiving HFRT were older (p = 0.001), more likely to be post-menopausal (p = 0.002), and less likely to receive concurrent chemotherapy (p = 0.004). Time to bleeding cessation was significantly shorter for patients receiving HFRT (log-rank p < 0.001) with median time to bleeding cessation of 5 days (HFRT) versus 16 days (CFRT). Stratification by dose-per-fraction revealed a dose-response effect with more rapid bleeding cessation with increased dose-per-fraction. While HFRT, age, recurrent disease, prior pelvic RT, and prior systemic therapy were associated with time to bleeding cessation on univariable analysis, HFRT was the only factor significantly associated with time to bleeding cessation in the final multivariable model (HR 3.26, p = 0.008). CONCLUSIONS: Patients with continuous VB from GYN tumors receiving HFRT experienced more rapid bleeding cessation than those receiving CFRT. For patients with severe VB, initiation of HFRT to control malignancy related bleeding quickly may be warranted.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Moradi LA, Schneider CS, Deshane AS, et al. Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy. Radiat Oncol. 2022. PMID: 35164826. doi:10.1186/s13014-022-01995-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。